As of 2025-04-26, the Relative Valuation of Verrica Pharmaceuticals Inc (VRCA) is (14.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.49 USD, the upside of Verrica Pharmaceuticals Inc based on Relative Valuation is -3119.5%.
The range of the Relative Valuation is (14.35) - (14.82) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 17.8x | 17.4x |
| Forward P/E multiples | 17.2x - 18.3x | 18.0x |
| Fair Price | (14.35) - (14.82) | (14.77) |
| Upside | -3034.2% - -3129.8% | -3119.5% |
| Date | P/E |
| 2025-04-25 | -0.59 |
| 2025-04-24 | -0.56 |
| 2025-04-23 | -0.55 |
| 2025-04-22 | -0.56 |
| 2025-04-21 | -0.56 |
| 2025-04-17 | -0.59 |
| 2025-04-16 | -0.57 |
| 2025-04-15 | -0.59 |
| 2025-04-14 | -0.66 |
| 2025-04-11 | -0.58 |
| 2025-04-10 | -0.53 |
| 2025-04-09 | -0.55 |
| 2025-04-08 | -0.69 |
| 2025-04-07 | -0.77 |
| 2025-04-04 | -0.64 |
| 2025-04-03 | -0.50 |
| 2025-04-02 | -0.53 |
| 2025-04-01 | -0.50 |
| 2025-03-31 | -0.53 |
| 2025-03-28 | -0.52 |
| 2025-03-27 | -0.52 |
| 2025-03-26 | -0.53 |
| 2025-03-25 | -0.57 |
| 2025-03-24 | -0.63 |
| 2025-03-21 | -0.67 |
| 2025-03-20 | -0.73 |
| 2025-03-19 | -0.74 |
| 2025-03-18 | -0.78 |
| 2025-03-17 | -0.78 |
| 2025-03-14 | -0.64 |
| 2025-03-13 | -0.71 |
| 2025-03-12 | -0.72 |
| 2025-03-11 | -0.78 |
| 2025-03-10 | -0.76 |
| 2025-03-07 | -0.73 |
| 2025-03-06 | -0.74 |
| 2025-03-05 | -0.75 |
| 2025-03-04 | -0.74 |
| 2025-03-03 | -0.77 |
| 2025-02-28 | -0.78 |
| 2025-02-27 | -0.71 |
| 2025-02-26 | -0.85 |
| 2025-02-25 | -0.81 |
| 2025-02-24 | -0.83 |
| 2025-02-21 | -0.88 |
| 2025-02-20 | -0.89 |
| 2025-02-19 | -0.89 |
| 2025-02-18 | -0.88 |
| 2025-02-14 | -0.88 |
| 2025-02-13 | -0.78 |